Skip to content

Celcuity CELC Interest Paid

Interest Paid at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$20.32M-12.7%
CG Oncology logo
CG OncologyCGON
$47K+82.5%
Tenet Healthcare logo
Tenet HealthcareTHC
$24M-75.8%
Medpace Holdings, Inc. logo
Medpace Holdings, Inc.MEDP
$0-100%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$65K-15.6%
Royalty Pharma logo
Royalty PharmaRPRX
$173.53M+25.0%

Other financials

Income statement

See full
Operating income-$50.5M-39.8%
Net income-$52.8M-42.8%
EPS (diluted)-$0.97-12.8%

Balance sheet

See full
Cash & equivalents$145.2M+781%
Total debt$137.9M+30.7%
Total equity$53.5M-38.2%
Total assets$410.2M+88.0%

Cash flow

See full
Operating cash flow-$55.1M-53.6%
CapEx$249.0K+315%
Free cash flow-$55.3M-54.0%

Valuation

See full
Market cap$4.28B+1,370%
Enterprise value$4.27B+1,086%

Returns & leverage

See full
Return on equity-275.2%-990pp
Debt / equity2.6×+1.4×
Current ratio12.3×+5.7×

Where this comes from

Reported directly by Celcuity in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: Celcuity’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Celcuity's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Celcuity's interest paid?
Celcuity (CELC) reported interest paid of $5.89M in Q1 2026.
How has Celcuity's interest paid changed year-over-year?
Celcuity's interest paid increased by 147.1% year-over-year, from $2.38M to $5.89M.
What is the long-term trend for Celcuity's interest paid?
Over 4 years (2021 to 2025), Celcuity's interest paid has grown at a 96.5% compound annual growth rate (CAGR), from $694.53K to $10.35M.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.